Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.

Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF‑06700841 In Subjects With Moderate To Severe Crohn's Disease

A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission